BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36376931)

  • 21. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer.
    Wang Y; Li Z; Zhang H; Jin H; Sun L; Dong H; Xu M; Zhao P; Zhang B; Wang J; Pan Y; Liu L
    Cancer Biol Ther; 2010 Aug; 10(4):376-82. PubMed ID: 20559021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer.
    Kikuchi H; Pino MS; Zeng M; Shirasawa S; Chung DC
    Cancer Res; 2009 Nov; 69(21):8499-506. PubMed ID: 19843849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia-inducible factor-1α promotes proliferation of airway smooth muscle cells through miRNA-103-mediated signaling pathway under hypoxia.
    Zhang C; Gao J; Zhu S
    In Vitro Cell Dev Biol Anim; 2021 Dec; 57(10):944-952. PubMed ID: 34888746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity.
    Ma X; Zhang H; Xue X; Shah YM
    J Biol Chem; 2017 Oct; 292(41):17046-17056. PubMed ID: 28848049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells.
    Hu CJ; Iyer S; Sataur A; Covello KL; Chodosh LA; Simon MC
    Mol Cell Biol; 2006 May; 26(9):3514-26. PubMed ID: 16611993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.
    Xiong Y; Liu Y; Xiong W; Zhang L; Liu H; Du Y; Li N
    Hum Reprod; 2016 Jun; 31(6):1327-38. PubMed ID: 27094478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZIC2 upregulates lncRNA SNHG12 expression to promote endometrial cancer cell proliferation and migration by activating the Notch signaling pathway.
    Cai P; Li G; Wu M; Zhang B; Bai H
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ; Athanasou NA
    J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells.
    Wan J; Qin J; Cao Q; Hu P; Zhong C; Tu C
    Genes Genomics; 2020 Mar; 42(3):317-324. PubMed ID: 31872384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-induced UBE2K promotes the malignant progression of HCC.
    Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y
    Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
    He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
    Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level.
    Liao Y; Lu W; Che Q; Yang T; Qiu H; Zhang H; He X; Wang J; Qiu M; Zou Y; Gu W; Wan X
    PLoS One; 2014; 9(6):e99907. PubMed ID: 24918449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells.
    Li Y; Qiu X; Zhang S; Zhang Q; Wang E
    Cancer Biol Ther; 2009 Feb; 8(4):322-30. PubMed ID: 19305150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury.
    Zhao M; Wang S; Zuo A; Zhang J; Wen W; Jiang W; Chen H; Liang D; Sun J; Wang M
    Cell Mol Biol Lett; 2021 Sep; 26(1):40. PubMed ID: 34479471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible factor-1alpha and -2alpha additively promote endothelial vasculogenic properties.
    Ben-Shoshan J; Maysel-Auslender S; Luboshits G; Barshack I; Polak-Charcon S; Tzahor E; Keren G; George J
    J Vasc Res; 2009; 46(4):299-310. PubMed ID: 19077391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
    Harashima N; Takenaga K; Akimoto M; Harada M
    Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.